Protherics PLC
Notification of Directors' Interests
London, UK; Brentwood, TN, US; 12 June 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, today announces the award, on 11 June 2007, of a conditional
right to receive 151,396 ordinary shares in Protherics ("Ordinary Shares") at a
price of 2 pence each under the terms of the Protherics PLC 2005 Long Term
Incentive Plan (the "LTIP"), to Saul Komisar, President of the Company's US
operations.
In addition to the above award, on 11 June 2007, Saul Komisar received a
performance bonus in the form of a conditional right to acquire 50,177 Ordinary
Shares at a price of 2 pence each under the terms of the Protherics PLC 2005
Deferred Bonus Plan.
Following the above awards, Saul Komisar holds options and conditional awards
over a total of 1,113,101 Ordinary Shares.
Protherics PLC also announces the grant, on 11 June 2007, of the following
options over Ordinary Shares in the Company under the terms of the LTIP at an
exercise price of 2 pence per share:
Name Position Number of
Options
Andrew Heath Chief Executive Officer 297,661
Barrington Riley Finance Director 161,702
James Christie Operations Director 161,702
Following the above grant of options, the above Directors hold options over the
following number of Ordinary Shares:
Andrew Heath 3,919,561
Barrington Riley 1,576,844
James Christie 1,388,010
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Anna Keeble +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
Protherics PLC announces Director/PDMR Shareholding
| Source: Protherics PLC
Cheshire, UK--(Marketwire - June 12, 2007) -